Home Business

India Eco Summit: Jubilant Organosys to invest Rs 250 cr

Drug maker Jubilant Organosys today said it has earmarked Rs 250 crore for its capacity expansion plans in the current fiscal. - India Eco Summit: Pfizer to launch another product in India - Daiichi Sankyo net income drops 45% in Apr-Sept - NEWSALERT: Shasun Chem reports net profit of Rs 2 cr - Aurobindo gets nod to market 2 more products in S Africa - Zydus Cadila net up 39% to Rs 132 cr - Crucial support at 4,950 "We are going to spend Rs 250 crore for capacity expansion. A majority of it would be spent on de-bottlenecking activities while a small portion of it would go for the R&D activities," Jubilant Organosys Chairman and Managing Director Shyam S Bhartia told reporters on the sidelines of World Economic Forum . When asked about the company"s proposed resolution to raise Rs 500 crore, he said it is only a "enabling" resolution and the time limit for the same has not been decided, adding that the resolution is for a one-year period.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Life insurers log 53% rise in first premium income
The insurance sector is making a strong comeback. Buoyed by a steep rise in sale of single premium policies, the industry clocked a 53.25 per cent rise in November.
Popular Articles

A K Bhattacharya: Waiting to exhale
A K Bhattacharya / New Delhi October 27, 2009, 0:48 IST

Pharma 2009: No medicine to cure adversity
Indian pharma industry found that it had no medicine to cure adversities that came its way in 2009 -- when it battled shipment seizures by EU authorities, tightened US regulations, Chinese drug piracy and currency fluctuations.